We believe in the responsible use of antibiotics important to human medicine* to help preserve their effectiveness for human and animal health in the future. Our policies do not permit the routine use of medically important antibiotics for the purpose of growth promotion or the habitual use of antibiotics for disease prevention.
Our focus is on refining antibiotic selection and administration, reducing non-therapeutic antibiotic use and, when possible, replacing antibiotics with long-term solutions to proactively prevent disease and protect animal health and welfare. We remain committed to the treatment of sick animals aligned with herd veterinarian direction to ensure the safety of our supply chain.
In August of 2016, we accomplished our goal to only source chickens in the U.S. not treated with antibiotics important to human medicine. Building on this progress, the use of Highest Priority Critically Important Antibiotics (HPCIAs) to human medicine has been eliminated from all chicken served in Australia, Brazil, Canada, Europe, Japan, South Korea and the U.S., with China expected to comply before the end of 2027.
We didn’t stop there. In December 2018, McDonald’s announced a policy to reduce the overall use of antibiotics important to human health, in our beef supply chain. Our policy covers 10 in-scope beef sourcing markets around the world, including the U.S., representing more than 85% of our global beef supply.
For more information on our approach to individual protein supply chains, visit Advocating for Responsible Antibiotic Use in Beef, Implementing a Global Chicken Antibiotics Policy, and Our Pork Antibiotics Use Policy.
*As defined by the World Health Organization.